← All stocks

LENZ Therapeutics, Inc.

LENZ Net selling
CIK 0001815776 #4144 in the set updated 18 Sep 2026
Bought (120 mo)
$39.58M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$66.86M
$0.00 on a plan · $261.02K straight out of an exercise
Sold at will
$66.60M
34 of 36 sales
Net
−$27.29M
−$27.03M against sales at will

By person

16 insiders · 74 transactions
0.9×

Evert Schimmelpennink holds only 0.9 times base salary in stock. $662.37K of shares against $690.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Evert Schimmelpennink last reported holding, valued at $8.57, the price Common Stock was last bought or sold at on the open market here, on 27 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Versant Venture Capital VI, L.P. entity
10% owner
$3.06M (1)
$66.60M (34)
−$63.54M
3,522,445
$30.19M
Samsara BioCapital, L.P.
10% owner
$17.13M (16)
+$17.13M
8,497,067
$72.82M
RA CAPITAL MANAGEMENT, L.P. entity
Director
$15.00M (2)
+$15.00M
4,014,094
$34.40M
Jerel Davis
Director
$3.06M (1)
+$3.06M
1,707,719
$14.64M
MCCOLLUM JAMES W
Director
$740.37K (2)
+$740.37K
536,065
$4.59M
Olsson Shawn
Chief Commercial Officer
$261.02K (2) scheduled
−$261.02K
4,733
$40.56K
Schimmelpennink Evert B.
President, CEO and Secretary
$251.41K (1)
+$251.41K
77,289
$662.37K
Chevallard Daniel R.
Chief Financial Officer
$164.28K (4)
+$164.28K
12,886
$110.43K
Shah Smital
Director
$99.99K (1)
+$99.99K
5,882
$50.41K
George Jeffrey P.
Director
$49.89K (1)
+$49.89K
5,592
$47.92K
Gutry Phil
CHIEF BUSINESS OFFICER
$20.05K (1)
+$20.05K
299,941
$2.57M
+56.2%
Lehrer-Graiwer Joshua
PRESIDENT AND CEO
1,161,670
$9.96M
+49.0%
Stultz Katherine V
CHIEF OPERATING OFFICER
216,020
$1.85M
+3.9%
KARSEN PERRY A
Director
164,034
$1.41M
+5.2%
JIMENEZ JOSEPH
Director
161,941
$1.39M
+55.8%
Odrich Marc
Chief Medical Officer
99,599
$853.56K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Chevallard Daniel R.
27 Mar 2026
Chief Financial Officer
Buy
7,500
$8.57
$64.28K
Schimmelpennink Evert B.
27 Mar 2026
President, CEO and Secretary
Buy
28,089
$8.95
$251.41K
George Jeffrey P.
27 Mar 2026
Director
Buy
5,592
$8.92
$49.89K
Chevallard Daniel R.
7 Nov 2025
Chief Financial Officer
Buy
2,178
$22.76
$49.56K
Chevallard Daniel R.
7 Nov 2025
Chief Financial Officer
Buy
20
$22.71
$454.20
MCCOLLUM JAMES W
7 Nov 2025
Director
Buy
10,500
$22.79
$239.28K
Chevallard Daniel R.
14 May 2024
Chief Financial Officer
Buy
3,188
$15.68
$49.99K
MCCOLLUM JAMES W
13 May 2024
Director
Buy indirect
31,332
$15.99
$501.09K
RA CAPITAL MANAGEMENT, L.P.
21 Mar 2024
Director
Buy indirect
64,971
$15.03
$976.51K
RA CAPITAL MANAGEMENT, L.P.
21 Mar 2024
Director
Buy indirect
933,038
$15.03
$14.02M
Samsara BioCapital, L.P.
12 Apr 2022
10% owner
Buy indirect
350,000
$4.08
$1.43M
Gutry Phil
11 Apr 2022
CHIEF BUSINESS OFFICER
Buy
5,000
$4.01
$20.05K
Samsara BioCapital, L.P.
11 Apr 2022
10% owner
Buy indirect
74,464
$4.07
$303.07K
Samsara BioCapital, L.P.
24 Jan 2022
10% owner
Buy indirect
23,000
$8.70
$200.10K
Samsara BioCapital, L.P.
21 Jan 2022
10% owner
Buy indirect
100,000
$8.99
$899.00K
Samsara BioCapital, L.P.
20 Jan 2022
10% owner
Buy indirect
43,105
$8.92
$384.50K
Samsara BioCapital, L.P.
19 Jan 2022
10% owner
Buy indirect
54,565
$9.24
$504.18K
Samsara BioCapital, L.P.
15 Dec 2021
10% owner
Buy indirect
22,329
$10.19
$227.53K
Samsara BioCapital, L.P.
22 Nov 2021
10% owner
Buy indirect
201,685
$10.15
$2.05M
Samsara BioCapital, L.P.
15 Oct 2021
10% owner
Buy indirect
2,300
$12.49
$28.73K
Samsara BioCapital, L.P.
14 Oct 2021
10% owner
Buy indirect
3,100
$12.50
$38.75K
Samsara BioCapital, L.P.
13 Oct 2021
10% owner
Buy indirect
45,400
$13.22
$600.19K
Samsara BioCapital, L.P.
8 Oct 2021
10% owner
Buy indirect
75,000
$13.12
$984.00K
Samsara BioCapital, L.P.
7 Oct 2021
10% owner
Buy indirect
9,021
$14.94
$134.77K
Samsara BioCapital, L.P.
6 Oct 2021
10% owner
Buy indirect
61,475
$13.83
$850.20K
Samsara BioCapital, L.P.
29 Jun 2021
10% owner
Buy indirect
15,000
$17.00
$255.00K
Samsara BioCapital, L.P.
29 Jun 2021
10% owner
Buy indirect
485,000
$17.00
$8.25M
Shah Smital
29 Jun 2021
Director
Buy indirect
5,882
$17.00
$99.99K
Jerel Davis
29 Jun 2021
Director
Buy indirect
180,000
$17.00
$3.06M
Versant Venture Capital VI, L.P.
29 Jun 2021
10% owner
Buy indirect
180,000
$17.00
$3.06M

What was left out

Form 4 filings counted 98
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 34
Transactions with no price 0
Shares from compensation/vesting 39,830,610
History held since 28 Jun 2021